Dilemmas in regulation of the market for pharmaceuticals
Year of publication: |
2003
|
---|---|
Authors: | Maynard, Alan ; Bloor, Karen |
Published in: |
Health affairs : at the intersection of health, health care, and policy. - Bethesda, Md. : Project Hope, ISSN 0278-2715, ZDB-ID 632712-6. - Vol. 22.2003, 3, p. 31-41
|
Subject: | Arzneimittelmarkt | Pharmaceutical market | Regulierung | Regulation | Gesundheitskosten | Health care costs | OECD-Staaten | OECD countries |
-
Pharmaceutical policies in OECD countries : reconciling social and industrial goals
Jacobzone, Stéphane, (2000)
-
Pharmaceutical Policies in OECD Countries : Reconciling Social and Industrial Goals
Jacobzone, S., (2000)
-
The economic driven by politics as values : the example of pharmaceuticals in France
Smith, Andy, (2017)
- More ...
-
The Economics of Health Policy
Maynard, Alan,
-
Non-steroidal anti-inflammatory drugs: a suitable case for treatment?
Bloor, Karen, (1995)
-
The Economics of the NHS Cancer Drugs Fund
Maynard, Alan, (2011)
- More ...